Interpace Diagnostics to Present at the Dawson James Securities 3rd Annual Small Cap Growth Stock Conference
October 17 2017 - 8:30AM
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) today announced
that Jack Stover, the Company’s President and CEO is scheduled to
present on Thursday October 19th at 11:30 am ET at the Dawson James
Securities 3rd Annual Small Cap Growth Conference at the Wyndham
Grand Jupiter at Harbourside Place, Jupiter, Florida. One-on-one
meetings will be held throughout the conference.
About Interpace Diagnostics Group,
Inc. Interpace Diagnostics is a fully integrated
commercial company that provides clinically useful molecular
diagnostic tests and pathology services for evaluating risk of
cancer by leveraging the latest technology in personalized medicine
for better patient diagnosis and management. The Company currently
has four commercialized molecular tests; PancraGEN® for the
diagnosis and prognosis of pancreatic cancer from pancreatic cysts;
ThyGenX®, for the diagnosis of thyroid cancer from thyroid nodules
utilizing a next generation sequencing assay and ThyraMIR®, for the
diagnosis of thyroid cancer from thyroid nodules utilizing a
proprietary gene expression assay; and MVPdX that helps
differentiates the local recurrence of lung cancer versus new
primary cancer formation. Interpace Diagnostics' mission
is to provide personalized medicine through molecular diagnostics
and innovation to advance patient care based on rigorous science.
For more information please visit the Company’s website at
www.interpacediagnostics.com.
CONTACTS:
Interpace DiagnosticsInvestor Relations:Paul Kuntz –
Redchippaul@redchip.com
Interpace Biosciences (NASDAQ:IDXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Interpace Biosciences (NASDAQ:IDXG)
Historical Stock Chart
From Apr 2023 to Apr 2024